Press Releases from Synagis (Pediatric RSV) (1 total)
Synagis (Pediatric RSV) - Forecast And Market Analysis To 2022
Summary
GlobalData has released its new PharmaPoint Drug Evaluation report, Synagis (Pediatric RSV) Forecast and Market Analysis to 2022. Respiratory syncytial virus (RSV) is a common…
Go To Page:
